BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28286738)

  • 61. Farnesylation-defective Rheb Increases Axonal Length Independently of mTORC1 Activity in Embryonic Primary Neurons.
    Choi S; Sadra A; Kang J; Ryu JR; Kim JH; Sun W; Huh SO
    Exp Neurobiol; 2019 Apr; 28(2):172-182. PubMed ID: 31138988
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ubiquitination of Rheb governs growth factor-induced mTORC1 activation.
    Deng L; Chen L; Zhao L; Xu Y; Peng X; Wang X; Ding L; Jin J; Teng H; Wang Y; Pan W; Yu F; Liao L; Li L; Ge X; Wang P
    Cell Res; 2019 Feb; 29(2):136-150. PubMed ID: 30514904
    [TBL] [Abstract][Full Text] [Related]  

  • 63. RUNX1/EGFR pathway contributes to STAT3 activation and tumor growth caused by hyperactivated mTORC1.
    Lin W; Wan X; Sun A; Zhou M; Chen X; Li Y; Wang Z; Huang H; Li H; Chen X; Hua J; Zha X
    Mol Ther Oncolytics; 2021 Dec; 23():387-401. PubMed ID: 34853810
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mechanosensitive Molecular Networks Involved in Transducing Resistance Exercise-Signals into Muscle Protein Accretion.
    Rindom E; Vissing K
    Front Physiol; 2016; 7():547. PubMed ID: 27909410
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Irisin promotes C2C12 myoblast proliferation via ERK-dependent CCL7 upregulation.
    Lee J; Park J; Kim YH; Lee NH; Song KM
    PLoS One; 2019; 14(9):e0222559. PubMed ID: 31518371
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Transforming Growth Factor-β-Activated Kinase 1 Is Required for Human FcγRIIIb-Induced Neutrophil Extracellular Trap Formation.
    Alemán OR; Mora N; Cortes-Vieyra R; Uribe-Querol E; Rosales C
    Front Immunol; 2016; 7():277. PubMed ID: 27486461
    [TBL] [Abstract][Full Text] [Related]  

  • 67. l-Asparaginase regulates mTORC1 activity via a TSC2-dependent pathway in pancreatic beta cells.
    Seike M; Asahara SI; Inoue H; Kudo M; Kanno A; Yokoi A; Suzuki H; Kimura-Koyanagi M; Kido Y; Ogawa W
    Biochem Biophys Res Commun; 2023 Apr; 652():121-130. PubMed ID: 36842323
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Rosiglitazone, an Agonist of PPARgamma, Inhibits Non-Small Cell Carcinoma Cell Proliferation In Part through Activation of Tumor Sclerosis Complex-2.
    Han S; Zheng Y; Roman J
    PPAR Res; 2007; 2007():29632. PubMed ID: 17597835
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Regulation of mTORC1 by amino acids in mammalian cells: A general picture of recent advances.
    Zhang S; Lin X; Hou Q; Hu Z; Wang Y; Wang Z
    Anim Nutr; 2021 Dec; 7(4):1009-1023. PubMed ID: 34738031
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Selective androgen receptor modulator, S42 has anabolic and anti-catabolic effects on cultured myotubes.
    Muta Y; Tanaka T; Hamaguchi Y; Hamanoue N; Motonaga R; Tanabe M; Nomiyama T; Nawata H; Yanase T
    Biochem Biophys Rep; 2019 Mar; 17():177-181. PubMed ID: 30705972
    [TBL] [Abstract][Full Text] [Related]  

  • 71. mTORC1 signaling in primary central nervous system lymphoma.
    Nitta N; Nakasu S; Shima A; Nozaki K
    Surg Neurol Int; 2016; 7(Suppl 17):S475-80. PubMed ID: 27512609
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Signaling crosstalk between the mTOR complexes.
    Xie J; Proud CG
    Translation (Austin); 2014; 2(1):e28174. PubMed ID: 26779402
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Purine Nucleotide Availability Regulates mTORC1 Activity through the Rheb GTPase.
    Emmanuel N; Ragunathan S; Shan Q; Wang F; Giannakou A; Huser N; Jin G; Myers J; Abraham RT; Unsal-Kacmaz K
    Cell Rep; 2017 Jun; 19(13):2665-2680. PubMed ID: 28658616
    [TBL] [Abstract][Full Text] [Related]  

  • 74. mTORC1 signalling mediates PI3K-dependent large lipid droplet accumulation in
    Mensah LB; Goberdhan DCI; Wilson C
    Biol Open; 2017 May; 6(5):563-570. PubMed ID: 28302666
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Glucose transporter 3 performs a critical role in mTOR-mediated oncogenic glycolysis and tumorigenesis.
    Zhang Y; Wei C; Xi J; Tang Z; Liang C
    Oncol Lett; 2015 Jun; 9(6):2809-2814. PubMed ID: 26137152
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Exosome Release Is Regulated by mTORC1.
    Zou W; Lai M; Zhang Y; Zheng L; Xing Z; Li T; Zou Z; Song Q; Zhao X; Xia L; Yang J; Liu A; Zhang H; Cui ZK; Jiang Y; Bai X
    Adv Sci (Weinh); 2019 Feb; 6(3):1801313. PubMed ID: 30775228
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mechanisms mediating the effects of alcohol and HIV anti-retroviral agents on mTORC1, mTORC2 and protein synthesis in myocytes.
    Hong-Brown LQ; Kazi AA; Lang CH
    World J Biol Chem; 2012 Jun; 3(6):110-20. PubMed ID: 22905289
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Development of an RHEB-Targeting Peptide To Inhibit mTORC1 Kinase Activity.
    Shams R; Ito Y; Miyatake H
    ACS Omega; 2022 Jul; 7(27):23479-23486. PubMed ID: 35847293
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Striatal Transcriptome and Interactome Analysis of
    Lee Y; Kim SG; Lee B; Zhang Y; Kim Y; Kim S; Kim E; Kang H; Han K
    Front Mol Neurosci; 2017; 10():201. PubMed ID: 28701918
    [TBL] [Abstract][Full Text] [Related]  

  • 80. mTORC1 activity oscillates throughout the cell cycle promoting mitotic entry and differentially influencing autophagy induction.
    Joshi JN; Lerner AD; Scallo F; Grumet AN; Matteson P; Millonig JH; Valvezan AJ
    bioRxiv; 2024 Feb; ():. PubMed ID: 38370755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.